Skip to main content

Peer Review reports

From: Evidence for the effectiveness of anti-hypertensive medicines included on the Chinese National Reimbursement Drug List

Original Submission
24 Oct 2018 Submitted Original manuscript
8 Dec 2018 Reviewed Reviewer Report - Jing Peng
10 Dec 2018 Reviewed Reviewer Report - Stella T Lartey
8 Jan 2019 Author responded Author comments - Wenbin Liu
Resubmission - Version 2
8 Jan 2019 Submitted Manuscript version 2
9 Jan 2019 Reviewed Reviewer Report - Jing Peng
23 Jan 2019 Reviewed Reviewer Report - Stella T Lartey
26 Jan 2019 Author responded Author comments - Wenbin Liu
Resubmission - Version 3
26 Jan 2019 Submitted Manuscript version 3
Publishing
29 Jan 2019 Editorially accepted
11 Feb 2019 Article published 10.1186/s12913-019-3937-0

You can find further information about peer review here.

Back to article page